» Articles » PMID: 23259700

Glucan-rich Polysaccharides from Pleurotus Sajor-caju (Fr.) Singer Prevents Glucose Intolerance, Insulin Resistance and Inflammation in C57BL/6J Mice Fed a High-fat Diet

Overview
Publisher Biomed Central
Date 2012 Dec 25
PMID 23259700
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Pleurotus sajor-caju (P. sajor-caju) has been extremely useful in the prevention of diabetes mellitus due to its low fat and high soluble fiber content for thousands of years. Insulin resistance is a key component in the development of diabetes mellitus which is caused by inflammation. In this study, we aimed to investigate the in vivo efficacy of glucan-rich polysaccharide of P. sajor-caju (GE) against diabetes mellitus and inflammation in C57BL/6J mice fed a high-fat diet.

Methods: Diabetes was induced in C57BL/6J mice by feeding a high-fat diet. The mice were randomly assigned to 7 groups (n=6 per group). The control groups in this study were ND (for normal diet) and HFD (for high-fat diet). The treated groups were ND240 (for normal diet) (240 mg/kg b.w) and HFD60, HFD120 and HFD240 (for high-fat), where the mice were administrated with three dosages of GE (60, 120, 240 mg GE/kg b.w respectively). Metformin (2 mg/kg b.w) served as positive control. The glucose tolerance test, glucose and insulin levels were measured at the end of 16 weeks. Expressions of genes for inflammatory markers, GLUT-4 and adiponectin in the adipose tissue of the mice were assessed. One-way ANOVA and Duncan's multiple range tests (DMRT) were used to determine the significant differences between groups.

Results: GE treated groups improved the glucose tolerance, attenuated hyperglycemia and hyperinsulinemia in the mice by up-regulating the adiponectin and GLUT-4 gene expressions. The mice in GE treated groups did not develop insulin resistance. GE also down-regulated the expression of inflammatory markers (IL-6, TNF-α, SAA2, CRP and MCP-1) via attenuation of nuclear transcription factors (NF-κB).

Conclusion: Glucan-rich polysaccharide of P. sajor-caju can serve as a potential agent for prevention of glucose intolerance, insulin resistance and inflammation.

Citing Articles

A comprehensive review on multifunctional bioactive properties of elm oyster mushroom (Bull.) Redhead (Agaricomycetes): Current research, challenges and future trends.

Aditya , Neeraj , Bhatia J, Yadav A Heliyon. 2025; 11(2):e41418.

PMID: 39897838 PMC: 11782987. DOI: 10.1016/j.heliyon.2024.e41418.


New Insights into Chemical Profiles and Health-Promoting Effects of Edible Mushroom (Vent ex. Pers.) Fischer: A Review.

Kumar Y, Xu B J Fungi (Basel). 2025; 11(1).

PMID: 39852494 PMC: 11767163. DOI: 10.3390/jof11010075.


Exploring Edible Mushrooms for Diabetes: Unveiling Their Role in Prevention and Treatment.

Shamim M, Mishra A, Kausar T, Mahanta S, Sarma B, Kumar V Molecules. 2023; 28(6).

PMID: 36985818 PMC: 10058372. DOI: 10.3390/molecules28062837.


The effects of hot air-dried white button mushroom powder on glycemic indices, lipid profile, inflammatory biomarkers and total antioxidant capacity in patients with type-2 diabetes mellitus: A randomized controlled trial.

Hashemi Yusefabad H, Hosseini S, Zakerkish M, Cheraghian B, Alipour M J Res Med Sci. 2022; 27:49.

PMID: 36092487 PMC: 9450248. DOI: 10.4103/jrms.JRMS_513_20.


Effects of bioactive compounds from Pleurotus mushrooms on COVID-19 risk factors associated with the cardiovascular system.

Dos Reis E, Cavalheiro Schenkel P, Camassola M J Integr Med. 2022; 20(5):385-395.

PMID: 35879221 PMC: 9271422. DOI: 10.1016/j.joim.2022.07.002.


References
1.
Dandona P, Aljada A, Bandyopadhyay A . Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2003; 25(1):4-7. DOI: 10.1016/j.it.2003.10.013. View

2.
Terra X, Pallares V, Ardevol A, Blade C, Fernandez-Larrea J, Pujadas G . Modulatory effect of grape-seed procyanidins on local and systemic inflammation in diet-induced obesity rats. J Nutr Biochem. 2010; 22(4):380-7. DOI: 10.1016/j.jnutbio.2010.03.006. View

3.
Simpson R, Shaw J, Zimmet P . The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century. Diabetes Res Clin Pract. 2003; 59(3):165-80. DOI: 10.1016/s0168-8227(02)00275-9. View

4.
Mohanty P, Aljada A, Ghanim H, Hofmeyer D, Tripathy D, Syed T . Evidence for a potent antiinflammatory effect of rosiglitazone. J Clin Endocrinol Metab. 2004; 89(6):2728-35. DOI: 10.1210/jc.2003-032103. View

5.
Pramanik M, Mondal S, Chakraborty I, Rout D, Islam S . Structural investigation of a polysaccharide (Fr. II) isolated from the aqueous extract of an edible mushroom, Pleurotus sajor-caju. Carbohydr Res. 2005; 340(4):629-36. DOI: 10.1016/j.carres.2004.12.032. View